Artal Group’s BridgeBio Pharma BBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500,000	Closed	-$8.29M	–	118
2023 Q1	$8.29M	Buy	500,000 +250,000	+100%	+$4.15M	0.49%	46
2022 Q4	$1.91M	Hold	250,000	–	–	0.11%	87
2022 Q3	$2.49M	Hold	250,000	–	–	0.11%	78
2022 Q2	$2.27M	Hold	250,000	–	–	0.12%	88
2022 Q1	$2.54M	Hold	250,000	–	–	0.11%	106
2021 Q4	$4.17M	Hold	250,000	–	–	0.11%	105
2021 Q3	$11.7M	Sell	250,000 -25,000	-9%	-$1.17M	0.26%	66
2021 Q2	$16.8M	Buy	275,000 +25,000	+10%	+$1.52M	0.34%	56
2021 Q1	$15.4M	Sell	250,000 -50,000	-17%	-$3.08M	0.27%	67
2020 Q4	$21.3M	Sell	300,000 -100,000	-25%	-$7.11M	0.46%	51
2020 Q3	$15M	Sell	400,000 -200,000	-33%	-$7.5M	0.36%	48
2020 Q2	$19.6M	Buy	600,000 +50,000	+9%	+$1.63M	0.55%	35
2020 Q1	$16M	Buy	550,000 +350,000	+175%	+$10.2M	0.67%	29
2019 Q4	$7.01M	Hold	200,000	–	–	0.27%	53
2019 Q3	$4.29M	Hold	200,000	–	–	0.17%	66
2019 Q2	$5.39M	Buy	+200,000	New	+$5.39M	0.22%	66